Form 4: Cardlytics CEO Karim Temsamani Reports Stock Transactions

Cardlytics CEO Karim Temsamani reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• On June 1, 2024, Karim Temsamani, CEO of Cardlytics, Inc., had 84,079 Restricted Stock Units (RSUs) vest.
• These RSUs represent a contingent right to receive one share of Cardlytics common stock or its cash equivalent.
• On June 4, 2024, Temsamani sold 43,129 shares of common stock at a weighted average price of $8.655 per share.
• The sale was solely to satisfy tax withholding obligations resulting from the RSU vesting.
• Following these transactions, Temsamani directly owns 385,530 shares of Cardlytics common stock and 756,710 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions. The sale of shares to cover taxes is a neutral event.

Positives

• The vesting of RSUs indicates continued compensation and alignment of the CEO's interests with the company's performance.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's performance and future prospects.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders due to the increased supply of shares, but it is primarily driven by tax obligations.

Key Dates